Targeting the root of cancer

Jan 19, 2005

Cambridge Scientists develop technology that could lead to effective cancer treatments

University of Cambridge scientists have developed a new technology that could potentially lead to more targeted and effective treatments for some cancers and ultimately rid the body of the disease.
Developed by Dr Toru Kondo, a neurobiologist at the Centre for Brain Repair at the University of Cambridge and colleagues from Kumamoto University in Japan, the technology separates cancer stem cells from cancer cell lines making it possible to target the 'parent' cancer stem cell and potentially destroy the source of the malignant tumours, while leaving normal stem cells unharmed.

The technology, derived from the premise that some cancer cells behave similarly to stem cells in that they are capable of unlimited proliferation, have the ability to give rise to multi-lineage cells, and may be difficult to eradicate with standard anti-cancer treatments. The scientists showed that certain cancer cell lines contain cancer stem cells that are prolific in their ability to produce a massive number of cancer cells and so create malignant tumours.

Dr Kondo says in order to successfully eliminate cancer stem cells, it is important that their unique targetable features be identified. For example, cell-surface proteins (membrane proteins) that are specific to cancer stem cells can be targeted with specific antibodies to kill the cancer stem cells. Similarly, other unique cancer stem cell targets could be hit with additional classes of drug compounds including small molecules. As a result of this type of targeted therapy the danger of recurrence of cancer would be eliminated.

Current treatments such as chemotherapy and radiation although successful at destroying cancer cells (i.e. tumor bulk) are unable to completely eliminate the critical cancer stem cells, hence allowing them to recreate the cancer. It is therefore believed that cancer stem cells are the root for the malignancy.

The University of Cambridge has licensed the technology to a U.S.-based Biotechnology Company, Stemline Therapeutics, a leader in this area, in return for milestone payments and royalties on products that will be used for cancer treatments. The University believes that Stemline is the ideal partner to protect, develop and advance oncology compounds arising from this collaboration through pre-clinical development and ultimately into human trials.

Dr Kondo will collaborate with Stemline Therapeutics in developing the technology further.

The technology and potential treatment can be used in conjunction with existing cancer treatments, targeting and destroying both cancer stem cells and cancer cells.

"Many cancers contain cancer stem cells that are responsible for their malignancy and in order to cure cancer they have to be eliminated. Our findings provide a simple and general strategy for doing so and I am optimistic that working along with Stemline Therapeutics will yield important advances in cancer treatments," said Dr Kondo.

Ivan Bergstein, CEO of Stemline Therapeutics, added: "Once we have eradicated the cancer stem cells, in essence we have destroyed the engine responsible for treatment failure and disease recurrence, the major problems when fighting cancer. Importantly, Dr. Kondo has developed an exciting new system to both isolate cancer stem cells and to screen drug candidates for anti-cancer stem cell activity."

Commenting on the agreement David Secher, Director of Research Services at the University of Cambridge said: "Cancer is a disease that affects almost everyone, directly or indirectly. We are very pleased with the agreement between Stemline Therapeutics and the University and hopeful that this collaboration will result in effective cancer therapeutics."

Source: University of Cambridge

Explore further: Cougars' diverse diet helped them survive the Pleistocene mass extinction

add to favorites email to friend print save as pdf

Related Stories

New patenting guidelines are needed for biotechnology

18 hours ago

Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy.

Analyzing living cells quickly and accurately

Apr 02, 2014

In order to investigate inflammation, tumors or stem cells, medical practitioners analyze living cells. Non-invasive optical procedures such as Raman spectroscopy accelerate this procedure. Researchers have ...

Recommended for you

Not just the poor live hand-to-mouth

13 hours ago

When the economy hits the skids, government stimulus checks to the poor sometimes follow. Stimulus programs—such as those in 2001, 2008 and 2009—are designed to boost the economy quickly by getting cash ...

Math modeling handbook now available

16 hours ago

Math comes in handy for answering questions about a variety of topics, from calculating the cost-effectiveness of fuel sources and determining the best regions to build high-speed rail to predicting the spread ...

Archaeologists, tribe clash over Native remains

17 hours ago

Archaeologists and Native Americans are clashing over Indian remains and artifacts that were excavated during a construction project in the San Francisco Bay Area, but then reburied at an undisclosed location.

Male-biased tweeting

19 hours ago

Today women take an active part in public life. Without a doubt, they also converse with other women. In fact, they even talk to each other about other things besides men. As banal as it sounds, this is far ...

User comments : 0

More news stories

Male-biased tweeting

Today women take an active part in public life. Without a doubt, they also converse with other women. In fact, they even talk to each other about other things besides men. As banal as it sounds, this is far ...

Not just the poor live hand-to-mouth

When the economy hits the skids, government stimulus checks to the poor sometimes follow. Stimulus programs—such as those in 2001, 2008 and 2009—are designed to boost the economy quickly by getting cash ...

Archaeologists, tribe clash over Native remains

Archaeologists and Native Americans are clashing over Indian remains and artifacts that were excavated during a construction project in the San Francisco Bay Area, but then reburied at an undisclosed location.

Phase transiting to a new quantum universe

(Phys.org) —Recent insight and discovery of a new class of quantum transition opens the way for a whole new subfield of materials physics and quantum technologies.

Imaging turns a corner

(Phys.org) —Scientists have developed a new microscope which enables a dramatically improved view of biological cells.